Mission Our flagship product Intelligent Care Platform drew inspiration from a study showing that checking in with oncology patients just once a week could reduce ER visits by 20-33% and increase overall survival by 20% – on par with the benefits of the best new oncology drugs developed in the last 10 years – by catching adverse effects earlier. Our digital symptom monitoring system, paired with a clinical dashboard that helps providers with triage and decision support tools, has shown highly promising results so far.
Intelligent Care Platform and our other products to support practices are in use in oncology clinics serving 550,000 patients and growing.
Description Canopy is a Series A ($13M raised to date, led by GSR Ventures and Samsung NEXT) startup transforming oncology care through software. Our Intelligent Care Platform improves patient outcomes and quality of life through digital symptom monitoring and increases revenue for cancer centers by increasing time on treatment and capturing interventional clinical revenue. We are a team of 20 experts (with alums from SimilarWeb, Flatiron Health, Facebook, and Ambra Health) and in the next year we plan to grow to 50 employees and to scale our patient reach from 550K to 2M.
Canopy has real impact on the lives of people who are suffering with cancer. Patients tell us that Canopy has literally changed their lives, enabling them to get the support they need during often harrowing cancer treatment. With Canopy, they feel “safer and supported” by care teams. Care teams rely on Canopy to help them scale and optimize support for cancer patients and users say they “couldn’t imagine a time without Canopy supporting their patient engagement workflow.” If you join Canopy, you will be part of having a true impact on the fastest growing chronic disease in the world.
Currently we have offices in New York City and Tel Aviv, Israel, as well as some remote team members.